Wire · opportunities
Ladera Medical Presents Full FASTEN Results Showing…
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 22 November 2026 · Fusion42 review
Ladera Medical presented full results from the FASTEN trial demonstrating that its Large Bore Closure System achieves rapid hemostasis and a strong safety profile in 55 patients undergoing transfemoral TAVR/TAVI procedures with 98.1% freedom from major access-site complications at 30 days.
This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it.
◆ ◆ The Wire takeaway
You have a new, single-device option that closes large arterial punctures quickly without leaving implants inside the artery. This changes operational risks for cardiovascular interventionists and opens a door to tighter procedural workflows.
◆ Coverage
2 sources · 22 Nov 2026
◆ Related on Wire
◆ Topics